3rd Quarter - Report
STANTON PARK GROUP for VERTEX PHARMACEUTICALS INCORPORATED
Firm
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; pharmaceutical pricing; awareness of cystic fibrosis; promoting reimbursement policies that protect patient access to pharmaceuticals;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA MARLENE BERGMAN New | LA, Rep. Mike Crapo; LA, Senator Mike Crapo |
| JAMES DERDERIAN | — |
| VALERIE HENRY | — |
| JOSEPH RACHINSKY | — |
| ERIN STRAWN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.